Pages that link to "Q45849568"

The following pages link to Persistence of hepatitis B virus DNA demonstrated by polymerase chain reaction in serum and liver after loss of HBsAg induced by antiviral therapy (Q45849568):

Displaying 31 items.

• Hepatitis B and cancer: A practical guide for the oncologist (Q26776468) (← links)
• Detection of replicative hepatitis C virus sequences in hepatocellular carcinoma (Q27478449) (← links)
• Treatment of hepatitis B in decompensated liver cirrhosis (Q35207784) (← links)
• Hepatitis B virus. New and evolving issues (Q35224757) (← links)
• Reducing the risk of hepatitis B virus transfusion-transmitted infection (Q35683881) (← links)
• Chronic hepatitis B virus infection in the Asia-Pacific region and Africa: review of disease progression (Q36157148) (← links)
• Fibrogenesis in cirrhosis. Potential for therapeutic intervention (Q36368951) (← links)
• Diagnosis and management of clinical and subclinical cobalamin deficiency: advances and controversies (Q36421163) (← links)
• Clinical and virological features of occult hepatitis B in patients with HBsAg seroclearance post-treatment or spontaneously. (Q39080534) (← links)
• Long-term effect of interferon therapy in chronic hepatitis B. (Q40390263) (← links)
• Interferons for viral hepatitis (Q40399739) (← links)
• Laboratory diagnosis of human hepatitis viruses (Q40600829) (← links)
• Polymerase chain reaction for the diagnosis of hepatitis B and C viral hepatitis (Q40915918) (← links)
• New treatments for chronic viral hepatitis B and C. (Q41157490) (← links)
• Kinetics of hepatitis B surface antigen loss in patients with HBeAg-positive chronic hepatitis B treated with tenofovir disoproxil fumarate (Q42204755) (← links)
• Retrospective analysis of non-A-E hepatitis: possible role of hepatitis B and C virus infection (Q43041044) (← links)
• Disappearance of serum hepatitis B virus DNA by polymerase chain reaction after adenine arabinoside 5‘‐monophosphate therapy in chronic hepatitis B (Q43450664) (← links)
• Spontaneous hepatitis B surface antigen clearance in a long-term follow-up study of patients with chronic type B hepatitis. Lack of correlation with hepatitis C and D virus superinfection. (Q44063012) (← links)
• Anti-pre-S responses and viral clearance in chronic hepatitis B virus infection (Q44323057) (← links)
• Treatment with Peg-interferon alpha-2b for HBeAg-positive chronic hepatitis B: HBsAg loss is associated with HBV genotype (Q44520576) (← links)
• HBsAg seroclearance in chronic hepatitis B in the Chinese: virological, histological, and clinical aspects. (Q44927737) (← links)
• Incidence of hepatitis B viraemia, detected using the polymerase chain reaction, after successful therapy of hepatitis B virus carriers with interferon-alpha (Q45102351) (← links)
• Persistence of hepatitis B virus DNA in serum and liver from patients with chronic hepatitis B after loss of HBsAg (Q45760693) (← links)
• De novo and apparent de novo hepatitis B virus infection after liver transplantation. (Q45764192) (← links)
• Demonstration of hepatitis B virus DNA by polymerase chain reaction in the serum and the liver after spontaneous or therapeutically induced HBeAg to anti-HBe or HBsAg to anti-HBs seroconversion in patients with chronic hepatitis B. (Q45858583) (← links)
• Hepatitis B virus DNA in peripheral-blood mononuclear cells in chronic hepatitis B after HBsAg clearance (Q45865389) (← links)
• Infectivity of blood from PCR-positive, HBsAg-negative, anti-HBs-positive cases of resolved hepatitis B infection. (Q52843861) (← links)
• Re-evaluation of α-interferon treatment of chronic hepatitis B using polymerase chain reaction (Q58236392) (← links)
• Interferon treatment in patients with chronic hepatitis B: A meta-analysis of the published literature (Q58803518) (← links)
• High incidence of hepatitis B infections among chronic hepatitis cases of unknown aetiology (Q73805667) (← links)
• Clinical and histological outcome after hepatitis B e antigen to antibody seroconversion in children with chronic hepatitis B (Q77906234) (← links)